Keynote Speakers

2019 Schneerson-Robbins Prize Awardee
Kathryn M. Edwards

Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA

View full bio

2019 Edward Jenner Lifetime Achievement Awardee
Rino Rappuoli

Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA

Rino Rappuoli is Chief Scientist and Head External R&D at GSK Vaccines, based in Siena, Italy and Professor at Imperial College. Prior positions: head of Vaccine R&D at Novartis, CSO of Chiron Corporation, head for R&D at Sclavo.

View full bio

Invited Speakers

Sean Bennett

Emergent Biosolutions, USA

View full bio

Aaron Esser Kahn

University of California, Irvine, USA

View full bio

Helena Maltezou

Hellenic Center for Disease Control and Prevention, Athens, Greece

Dr. Maltezou received her Medical Diploma and her PhD from the University of Crete, Greece, and had her post-doctoral fellowship during 1994-1997 on viral infections in immunocompromised patients at M.D. Anderson Cancer Center, Houston. During 1997-2001 Dr Maltezou was trained at the Pediatric Residency Program of the University of Athens, Greece, and during 2001-2003 in Infectious Diseases at the Universite de la Mediterannee, Marseille, France.

View full bio

Eng Eong Ooi

Duke-NUS Medical School, Singapore

View full bio

Yong Poolvorawan

Chulalongkorn University, Thailand

Talk Title: Elimination of hepatitis by the year 2030; role of hepatitis vaccines

View full bio

Kanta Subbarao

WHO Melbourne, Australia

Dr. Kanta Subbarao is the Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity and Professor, Department of Microbiology and Immunology, The University of Melbourne. She is a virologist and a physician with specialty training in pediatrics and pediatric infectious diseases.

View full bio